Talen Energy Corp <TLN.O>: Barclays cuts target price to $408 from $411
TLN•Related News
GSK, Hansoh's bone cancer drug meets main goal in late-stage trial
GSK•
Oshkosh FY26 Q2 adjusted EPS drops 15.8% to $2.87; net sales rise 6.7% to $2.92 billion
OSK•
Oshkosh Q2 profit beats on improved pricing
OSK•
Coca-Cola Q2 revenue beats on demand for sodas
KO•
Tenet Healthcare Corp <THC.N>: Morgan Stanley raises target price to $274 from $254
THC•